Preterm Birth Prevention and Management Market Size

Preterm Birth Prevention and Management Market Size

The global preterm birth prevention and management market was valued at USD 1.8 billion in 2024 and is expected to exhibit growth at a CAGR of 7.7% from 2025 to 2034. The market growth is attributed to the increasing preterm birth rates, advancements in medical technology, rising prevalence of maternal risk factors, and growing focus on neonatal care, among other contributing factors.

To get key market trends

  Download Free Sample

The preterm birth remains a primary cause of neonatal morbidity and mortality worldwide. For instance, according to the World Health Organization (WHO), an estimated 15 million babies are born preterm each year, and this number is rising. Additionaly, in 2022, preterm birth complications were responsible for approximately 1 million deaths in children under five years. The increasing incidence of preterm births has created a higher demand for prevention and management solutions, driving market expansion.
 

Moreover, technological innovations in prenatal care, such as improved diagnostic tools, monitoring systems, and treatments, are enabling better management of high-risk pregnancies, leading to enhanced outcomes for preterm infants
 

Preterm birth prevention and management refers to the strategies and medical interventions aimed at preventing or managing premature births (before 37 weeks of gestation). This includes the use of therapies like progesterone, tocolytics, corticosteroids, and magnesium sulfate to delay labor, promote fetal lung maturity, and manage complications.